Severe acute respiratory syndrome (SARS)

Severe acute respiratory syndrome (SARS)
Name	Severe acute respiratory syndrome
Specialty	Infectious disease, Pulmonology, Virology

Severe acute respiratory syndrome (SARS) is an acute viral respiratory illness that emerged in the early 21st century and caused a global outbreak recognized for high morbidity and international spread. The syndrome prompted coordinated responses from international organizations, national health agencies, and research institutions, and led to major developments in infectious disease surveillance, outbreak containment, and World Health Organization policy. The causative agent was identified rapidly through collaboration among laboratories, public health authorities, and academic centers.

Overview

SARS was first reported in Guangdong province and subsequently affected cities including Hong Kong, Toronto, Singapore, Beijing, and Taipei. The outbreak prompted emergency measures by the World Health Organization, travel advisories involving Hong Kong International Airport, and investigations by teams from the Centers for Disease Control and Prevention, Public Health Agency of Canada, and national ministries such as the Ministry of Health (Singapore). Major affected organizations and responses included the World Health Assembly, the United Nations, the European Centre for Disease Prevention and Control, and research consortia at institutions like the University of Toronto, the Chinese Academy of Sciences, and the National Institutes of Health. The epidemic influenced policy at bodies such as the G7 Summit and triggered legal and economic actions in markets including the Hong Kong Stock Exchange and Toronto Stock Exchange.

Virology and Pathogenesis

The etiologic agent was identified as a novel coronavirus by virologists at laboratories including the University of Hong Kong and the Centers for Disease Control and Prevention. The virus, a member of the Coronaviridae family, was characterized by teams at the National Institute for Communicable Diseases (South Africa) and the Institut Pasteur. Molecular studies using sequencing platforms from groups at Wellcome Sanger Institute, Cold Spring Harbor Laboratory, and the Broad Institute elucidated its genome and relation to animal reservoirs such as bats examined by researchers at Wuhan Institute of Virology and China Agricultural University. Pathogenesis research involved investigators affiliated with Harvard Medical School, Johns Hopkins University School of Medicine, Imperial College London, and University College London, revealing viral entry via receptor interactions studied in laboratories collaborating with the Max Planck Institute and the Karolinska Institute. Host immune responses were profiled by teams at the Pasteur Institute, the Institut National de la Santé et de la Recherche Médicale, and the National Cancer Institute, which informed understanding of cytokine responses and lung injury mechanisms described in studies published by groups at Yale School of Medicine and Stanford University School of Medicine.

Epidemiology and Transmission

Epidemiological investigations by the World Health Organization, Centers for Disease Control and Prevention, Public Health Agency of Canada, and national ministries mapped transmission chains involving healthcare settings such as Prince of Wales Hospital (Hong Kong), long-term care facilities investigated by Toronto Public Health, and hotel-based clusters implicating venues like the Metropole Hotel (Hong Kong). Case counts, attack rates, and reproductive number estimates were produced by modelers at London School of Hygiene & Tropical Medicine, Imperial College London, University of Oxford, and the University of Melbourne. Travel-associated spread was analyzed by teams at International Air Transport Association, Federal Aviation Administration, and port health authorities in San Francisco, Sydney, Bangkok, and Dubai. Zoonotic origins were explored with fieldwork by the Wildlife Conservation Society, Smithsonian Institution, National Geographic Society, and veterinary researchers at Royal Veterinary College and Cornell University. Clusters linked to superspreading events prompted investigations by the World Health Organization and academic groups at Columbia University and University of Washington.

Clinical Features and Diagnosis

Clinically, patients presented to hospitals such as Mount Sinai Hospital (Toronto), Queen Mary Hospital (Hong Kong), and Tan Tock Seng Hospital with fever, cough, myalgia, and progressive hypoxemia, necessitating care in intensive care units at centers including Mayo Clinic and Cleveland Clinic. Diagnostic workflows incorporated radiology departments at Massachusetts General Hospital and laboratory services at Hospital for Sick Children (Toronto) using assays developed by teams at the Centers for Disease Control and Prevention, Roche Diagnostics, and academic labs at University of California, San Francisco. Differential diagnosis involved testing to exclude agents studied by the Institut Pasteur and pathogen-specific panels used by Quest Diagnostics and Laboratory Corporation of America. Clinical management guidelines were issued by professional bodies such as the Infectious Diseases Society of America, Royal College of Physicians, American Thoracic Society, and national ministries including Ministry of Health (Canada). Case definitions and surveillance case reporting were coordinated through platforms used by World Health Organization and national public health agencies.

Treatment and Management

Treatment was largely supportive, provided in tertiary centers like Johns Hopkins Hospital and Charité – Universitätsmedizin Berlin, with critical care interventions informed by research from European Society of Intensive Care Medicine, Society of Critical Care Medicine, and trials conducted at National Institutes of Health. Antiviral candidates and immunomodulatory therapies were explored in trials involving institutions such as University of Hong Kong, Chinese University of Hong Kong, University of Toronto, and pharmaceutical companies including Roche, GlaxoSmithKline, and Gilead Sciences. Infection control protocols adopted in hospitals referenced guidelines from the World Health Organization, Centers for Disease Control and Prevention, Public Health England, and the Australian Department of Health. Rehabilitation and long-term follow-up programs were implemented by clinics associated with University College London Hospitals and Mount Sinai Health System.

Public Health Response and Control Measures

Control measures included travel advisories issued by World Health Organization, screening policies at airports coordinated with International Air Transport Association, and quarantine and isolation orders executed by public health agencies such as Centers for Disease Control and Prevention, Public Health Agency of Canada, Department of Health (Hong Kong), and Ministry of Health (Singapore). Contact tracing and surveillance systems were deployed by teams at London School of Hygiene & Tropical Medicine, Harvard T.H. Chan School of Public Health, University of Toronto public health units, and municipal health departments in Toronto, Hong Kong, Singapore, and Beijing. Legal and ethical implications were debated in forums including the World Health Assembly, United Nations General Assembly, and academic centers at Yale Law School and Harvard Law School. The outbreak influenced preparedness planning at institutions such as the Pan American Health Organization, European Centre for Disease Prevention and Control, and national emergency operations centers including those of United States Department of Health and Human Services, Health Canada, and the Ministry of Health, Labour and Welfare (Japan).

Category:Viral respiratory diseases